Personal tools

MCL coexpression mm9:219: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000344!2.57e-39!15;UBERON:0000160!3.10e-34!31;UBERON:0001242!1.77e-32!13;UBERON:0000060!1.77e-32!13;UBERON:0001262!1.77e-32!13;UBERON:0004786!1.77e-32!13;UBERON:0004923!1.14e-23!24;UBERON:0005409!1.88e-21!47;UBERON:0003350!4.02e-19!9;UBERON:0004808!4.02e-19!9;UBERON:0001277!4.02e-19!9;UBERON:0000485!1.70e-15!11;UBERON:0002108!3.43e-15!4;UBERON:0000331!2.71e-12!3;UBERON:0002116!2.71e-12!3;UBERON:0001204!2.71e-12!3;UBERON:0001168!2.71e-12!3;UBERON:0001007!8.34e-09!116;UBERON:0001555!8.34e-09!116;UBERON:0007026!8.34e-09!116;UBERON:0004119!1.36e-08!118;UBERON:0000925!1.36e-08!118;UBERON:0006595!1.36e-08!118;UBERON:0001962!1.95e-08!2;UBERON:0001961!1.95e-08!2;UBERON:0001744!1.95e-08!2;UBERON:0004921!7.66e-07!114
|ontology_enrichment_uberon=UBERON:0000344!2.57e-39!15;UBERON:0000160!3.10e-34!31;UBERON:0001242!1.77e-32!13;UBERON:0000060!1.77e-32!13;UBERON:0001262!1.77e-32!13;UBERON:0004786!1.77e-32!13;UBERON:0004923!1.14e-23!24;UBERON:0005409!1.88e-21!47;UBERON:0003350!4.02e-19!9;UBERON:0004808!4.02e-19!9;UBERON:0001277!4.02e-19!9;UBERON:0000485!1.70e-15!11;UBERON:0002108!3.43e-15!4;UBERON:0000331!2.71e-12!3;UBERON:0002116!2.71e-12!3;UBERON:0001204!2.71e-12!3;UBERON:0001168!2.71e-12!3;UBERON:0001007!8.34e-09!116;UBERON:0001555!8.34e-09!116;UBERON:0007026!8.34e-09!116;UBERON:0004119!1.36e-08!118;UBERON:0000925!1.36e-08!118;UBERON:0006595!1.36e-08!118;UBERON:0001962!1.95e-08!2;UBERON:0001961!1.95e-08!2;UBERON:0001744!1.95e-08!2;UBERON:0004921!7.66e-07!114
|tfbs_overrepresentation_for_novel_motifs=0.0337853,0.00306044,0.113995,0.175377,0.11938,0.742587,0.29251,0.31767,0.348171,0.0493602,0.0681347,0.277896,0.491441,0.0921882,1.41157,0,0.199777,2.02667,0.00846381,0.216828,1.82358,0.668291,0.0917729,0.117677,0.530939,0.105276,0.140658,0.0583037,0.0141199,0.0329823,0.0532925,0.740605,0.108365,0.319439,0.139191,0.0416882,0.0337494,0.0797829,0.316009,0.402642,0.655882,0.0551024,0.431944,1.8302,0.203251,0.1645,0.151073,0.0641975,0.306141,0.352666,0.552653,0.118842,0.0287439,0.37598,0.389905,0.0955072,0.924041,0.262717,0.223586,0.0945544,0.254508,0.123779,0.233189,0.181599,0.100788,0.597583,0.503044,0.81757,0.251228,0.681742,0.0993148,0.737272,2.52217e-05,0.417048,0.0200148,0.442831,0.0185563,0.144582,0.242532,1.41641,0.34048,0.211086,0.123019,0.297743,0.325875,0.0116703,0.00822087,0.0114693,0.153906,0.971002,0.563419,0.329674,0.277951,0.0450587,0.00419546,0.895728,0.47974,0.279988,0.151219,0.0502445,0.211873,0.268528,0.36221,0.189022,0.188358,0.0549469,0.227389,0.062665,0.021161,0.0876002,0.306923,0.363613,0.225723,0.0701947,0.569603,0.648467,0.0288783,0.047388,0.581387,0.0951065,0.421465,0.504314,0.106172,0.14407,0.617553,0.686086,0.627857,0.273057,0.501748,0.267005,0.348935,0.381713,0.476627,0.102,1.43728,0.0561071,0.604363,0.0556016,0.54549,1.3282,0.940622,0.507078,0.361045,0.757844,1.63791,0.0552627,1.45493,1.28935,0.337991,0.252571,0.012097,0.0436816,0.377227,0.0205799,0.101553,0.443629,0.119365,0.153349,0.0331299,0.0360045,1.36373,0.868482,0.245404,0.0313438,1.62621,0.0980114,0.0332957,0.580563,0.0300372
}}
}}

Revision as of 18:00, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr11:68369811..68369821,+p5@Mfsd6l
Mm9::chr11:78734321..78734336,+p1@Nos2
Mm9::chr12:103965542..103965564,-p@chr12:103965542..103965564
-
Mm9::chr12:77896303..77896342,-p@chr12:77896303..77896342
-
Mm9::chr15:94459667..94459701,+p1@Tmem117
Mm9::chr16:18629886..18629899,-p@chr16:18629886..18629899
-
Mm9::chr16:33794199..33794208,+p7@Muc13
Mm9::chr16:33794221..33794247,+p5@Muc13
Mm9::chr16:34943355..34943373,-p@chr16:34943355..34943373
-
Mm9::chr17:24835239..24835290,+p1@Noxo1
Mm9::chr17:37004048..37004055,-p4@Trim15
Mm9::chr17:37004061..37004104,-p1@Trim15
Mm9::chr18:35886629..35886648,+p1@1700066B19Rik
Mm9::chr18:35886673..35886693,+p3@1700066B19Rik
Mm9::chr19:41337833..41337868,+p@chr19:41337833..41337868
+
Mm9::chr3:103636664..103636763,+p1@Bcl2l15
Mm9::chr4:133899408..133899421,+p9@Slc30a2
Mm9::chr6:78321036..78321044,+p@chr6:78321036..78321044
+
Mm9::chr6:78323455..78323458,-p@chr6:78323455..78323458
-
Mm9::chr6:78416391..78416410,+p@chr6:78416391..78416410
+
Mm9::chr6:78416506..78416522,-p@chr6:78416506..78416522
-
Mm9::chr6:78416766..78416773,+p@chr6:78416766..78416773
+
Mm9::chr6:78416806..78416819,+p@chr6:78416806..78416819
+
Mm9::chr6:78416808..78416822,-p@chr6:78416808..78416822
-
Mm9::chr6:78416850..78416860,-p@chr6:78416850..78416860
-
Mm9::chr6:78416874..78416888,-p@chr6:78416874..78416888
-
Mm9::chr6:78417498..78417509,-p@chr6:78417498..78417509
-
Mm9::chr6:78417510..78417520,-p@chr6:78417510..78417520
-
Mm9::chr6:78417539..78417569,-p@chr6:78417539..78417569
-
Mm9::chr6:78417572..78417600,-p@chr6:78417572..78417600
-
Mm9::chr6:78417835..78417870,-p@chr6:78417835..78417870
-
Mm9::chr6:78417872..78417919,-p@chr6:78417872..78417919
-
Mm9::chr6:78418516..78418525,-p@chr6:78418516..78418525
-
Mm9::chr6:78418536..78418572,-p@chr6:78418536..78418572
-
Mm9::chr6:78418857..78418872,-p1@Reg3g
Mm9::chr7:108709377..108709380,-p1@Art2a-ps
Mm9::chr7:138141963..138141967,-p@chr7:138141963..138141967
-
Mm9::chr9:5299402..5299415,+p@chr9:5299402..5299415
+
Mm9::chr9:65270665..65270680,-p2@Ostb
Mm9::chr9:65270702..65270717,-p1@Ostb


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0006953acute-phase response0.0275006151367407
GO:0035300inositol trisphosphate 5/6-kinase activity0.0278036487152797
GO:0051765inositol tetrakisphosphate kinase activity0.0278036487152797
GO:0047325inositol tetrakisphosphate 1-kinase activity0.0278036487152797
GO:0016176superoxide-generating NADPH oxidase activator activity0.0280353446395364
GO:0043647inositol phosphate metabolic process0.0280353446395364
GO:0032957inositol trisphosphate metabolic process0.0280353446395364
GO:0002526acute inflammatory response0.0280353446395364
GO:0006950response to stress0.0307422181886886



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
mucosa2.57e-3915
intestine3.10e-3431
intestinal mucosa1.77e-3213
anatomical wall1.77e-3213
wall of intestine1.77e-3213
gastrointestinal system mucosa1.77e-3213
organ component layer1.14e-2324
gastrointestinal system1.88e-2147
epithelium of mucosa4.02e-199
gastrointestinal system epithelium4.02e-199
intestinal epithelium4.02e-199
simple columnar epithelium1.70e-1511
small intestine3.43e-154
ileal mucosa2.71e-123
ileum2.71e-123
mucosa of small intestine2.71e-123
wall of small intestine2.71e-123
digestive system8.34e-09116
digestive tract8.34e-09116
primitive gut8.34e-09116
endoderm-derived structure1.36e-08118
endoderm1.36e-08118
presumptive endoderm1.36e-08118
gut-associated lymphoid tissue1.95e-082
mucosa-associated lymphoid tissue1.95e-082
lymphoid tissue1.95e-082
subdivision of digestive tract7.66e-07114


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:219&oldid=2561439"